𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults

✍ Scribed by Vinod K. Rustgi; Charles J. Schleupner; David S. Krause


Book ID
116116817
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
697 KB
Volume
13
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES